Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #38,201 to #38,250.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. TULP1 (2 revisions)
  2. TWF1 (2 revisions)
  3. TWIST2 (2 revisions)
  4. TXLNB (2 revisions)
  5. TXNIP (2 revisions)
  6. TYRO3 (2 revisions)
  7. TYROBP (2 revisions)
  8. TYRP1 (2 revisions)
  9. TYSND1 (2 revisions)
  10. T wave alternans for risk stratification during exercise stress testing (2 revisions)
  11. Tabebuia (2 revisions)
  12. Tabes Dorsalis case study one (2 revisions)
  13. Table of clinically important viruses (2 revisions)
  14. Table of medication secernated in kidney (2 revisions)
  15. Tacatuzumab tetraxetan (2 revisions)
  16. Tachycardia CT (2 revisions)
  17. Tachykinin peptides (2 revisions)
  18. Tachykinin receptor 1 (2 revisions)
  19. Taenia infection case study one (2 revisions)
  20. Taenia infection causes (2 revisions)
  21. Taenia infection classification (2 revisions)
  22. Taenia infection cost-effectiveness of therapy (2 revisions)
  23. Taenia infection future or investigational therapies (2 revisions)
  24. Taenia infection laboratory findings (2 revisions)
  25. Taenia infection natural history, complications and prognosis (2 revisions)
  26. Taenia infection other diagnostic studies (2 revisions)
  27. Taenia infection physical examination (2 revisions)
  28. Taenia infection primary prevention (2 revisions)
  29. Taenia infection surgery (2 revisions)
  30. Tafazzin (2 revisions)
  31. Tafenoquine (2 revisions)
  32. Tait-Bryan rotations (2 revisions)
  33. Talcosis (2 revisions)
  34. Taletrectinib (2 revisions)
  35. Talon cusp (2 revisions)
  36. Tamoxifen detailed information (2 revisions)
  37. Tamsulosin detailed information (2 revisions)
  38. Tamsulosin drug interactions (2 revisions)
  39. Tang Hsi Ryu syndrome (2 revisions)
  40. Tanner stage (2 revisions)
  41. Tanning activator (2 revisions)
  42. Tanning addiction (2 revisions)
  43. Tansy (2 revisions)
  44. Tapasin (2 revisions)
  45. Taplitumomab paptox (2 revisions)
  46. Tar (tobacco residue) (2 revisions)
  47. Tardive dysphrenia (2 revisions)
  48. Targeted therapy (2 revisions)
  49. Tarsal coalition (2 revisions)
  50. Tartrate-resistant acid phosphatase (2 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)